Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names

Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

;
error: Content is protected !!